The investment objective of the scheme is to provide returns that, before expenses, correspond to the total returns of the securities as represented by Nifty Capital Market Total Return Index, subject ...
Read More...To achieve long-term capital appreciation by predominantly investing in equity and equity-related instruments of large, mid and small-cap companies. However, there can be no assurance that the investm ...
Read More...The investment objective of the scheme is to provide returns, before expenses, that commensurate with the performance of BSE Select Business Groups Index (TRI), subject to tracking error. However, the ...
Read More...The investment objective of the scheme is to generate long-term capital appreciation from a portfolio that is invested predominantly in equity and equity related securities of companies engaged in tra ...
Read More...To generate returns that are commensurate (before fees and expenses) with the performance of the Nifty India Digital Index (TRI), subject to tracking error. There is no assurance that the investment o ...
Read More...The scheme aims to provide long-term capital growth from an actively managed diversified portfolio of equity & equity-related securities of companies that exhibit strong momentum. The selection of sec ...
Read More...The investment objective of the scheme is to seek to generate returns through an actively managed diversified portfolio of debt and money market instruments such that the Macaulay duration of the port ...
Read More...The investment objective of the scheme is to replicate CRISIL IBX AAA Financial Services - Jan 2028 Index by investing in AAA rated financial services corporate bond issuers maturing on or before Janu ...
Read More...The investment objective of the scheme is to generate returns by investing in debt and money market instruments such that the Macaulay duration of the scheme portfolio is greater than 7 years. However ...
Read More...The primary investment objective of the scheme is to seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies. ...
Read More...